Matthew Duffy
Chief Business Officer
Replay available
NRX Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call
NRX Pharmaceuticals, Inc. (NASDAQ: NRXP) Q1 2025 earnings conference call, held 2025-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
NRX Pharmaceuticals Investor Relations
Investor Relations
Jonathan Javits
Founder, Chairman and CEO
Michael Abrams
Chief Financial Officer
Tom Schrader
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Nrx Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.259 Afternoon ladies and gentlemen and welcome to the NRX Pharmaceuticals first quarter 2025 00:00:05.259 -- 00:00:10.748 earnings call. At this time all lines are in a less lonely mode. 00:00:10.748 -- 00:00:13.853 Following the presentation we will conduct a question and answer session. 00:00:13.853 -- 00:00:19.242 If at any time during this call you require immediate assistance 00:00:19.242 -- 00:00:22.387 please press star zero for the operator. 00:00:22.387 -- 00:00:27.790 This call is being recorded on Thursday May 15, 2025. 00:00:27.790 -- 00:00:33.178 I would now like to turn the conference over to Matthew Duffy, Chief Business Officer. 00:00:33.178 -- 00:00:35.538 Please go ahead. 00:00:36.563 -- 00:00:39.026 Thank you, Andrew, and welcome, everyone. 00:00:39.026 -- 00:00:42.612 Before we proceed with the call, I would like to remind everyone that certain statements 00:00:42.612 -- 00:00:45.676 made during this call are forward-looking statements under U.S. 00:00:45.676 -- 00:00:50.383 federal securities laws. These statements are subject to risks and uncertainties because 00:00:50.383 -- 00:00:55.451 they could cause actual results to differ materially from historical 00:00:55.451 -- 00:00:58.418 experience or permanent expectations. 00:00:58.418 -- 00:01:02.422 Additional information concerning factors that could cause actual results to differ from 00:01:02.422 -- 00:01:07.648 statements made on this call is contained in our periodic reports filed with the FTC. 00:01:07.648 -- 00:01:11.933 The forward-looking statements made during this call speak only as of the date hereof, 00:01:11.933 -- 00:01:16.958 and the company undertakes no obligation to update or revise the forward-looking statements. 00:01:16.958 -- 00:01:21.664 I...